 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, will...

Stevanato Group to Livestream Inaugural Capital Markets Day on September 27, 2023

Stevanato Group S.p.A. 2023 Q2 - Results - Earnings Call Presentation

In a report released on July 28, Derik De Bruin from Bank of America Securities maintained a Buy rating on Stevanato Group (STVN Research Report)... In a report released on July 28, Derik De Bruin from Bank of America Securities maintained a Buy rating on Stevanato Group (STVN &#8211...

Stevanato Group (STVN) Gets a Buy from Bank of America Securities

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today announced its financial results for the second quarter of 2023. Second Quarter 2023 Highlights...

Stevanato Group Reports Second Quarter 2023 Financial Results

Stevanato Group S.p.A. (STVN) Q2 2023 Earnings Call Transcript

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will issue financial results for the second quarter of 2023 on Friday, July 28...

Stevanato Group to Report Second Quarter 2023 Financial Results on July 28, 2023

Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Stevanato Group (STVN Research Report) and MYT Netherland... Analysts have been eager to weigh in on the Industrial Goods sector with new ratings on Stevanato Group (STVN Research Report) and MYT Netherlands...

Analysts' Opinions Are Mixed on These Industrial Goods Stocks: Stevanato Group (STVN) and MYT Netherlands (MYTE)

Stevanato Group: Undeniable Quality, But Lacking Upside

Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology and life sciences industries, unveiled today Vertiva, the latest release of its patented On-Body Delivery System (OBDS), intended to be able to switch...

Stevanato Group Presents Vertiva, a Versatile On-Body Delivery System Platform for a Wide Range of Injectable Therapies and for Large Delivery Volumes (up to 10mL)

Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.

Watchers	81
52-Wk Low	$13.71
52-Wk High	$36.30

Market Cap	$8.04B
Volume (M)	216,246.00
52-Wk High	$36.30
52-Wk Low	$13.71

STVN Stevanato Group Spa

About

Feed

News

Sentiment

Earnings

Fundamentals